Glyphosate, the studies used by the European Union may not be reliable

Glyphosate, the studies used by the European Union may not be reliable

Environment · ·

An Austrian study has for the first time analysed the quality of the studies on the basis of which the European Union authorised the use of glyphosate.

Are the studies on the basis of which marketing authorisations for glyphosate were granted in Europe reliable? For the first time, two Austrian researchers have raised doubts about the quality of the analyses used by the European Union to approve the herbicide with which Monsanto, now Bayer, produces: Roundup.

Glyphosate authorised in Europe until the end of 2022

As is well known, glyphosate is the most widely used herbicide in the world. In EU member states its use is authorised until December 2022, thanks to a decision reached in 2017 by the Brussels Commission. But discussion of what comes next has already begun: last June, four member states provided the first results of the assessments that could allow glyphosate to be used on European agricultural land for a further five years.

Corporate studies asserting herbicide safety show many flaws, new analysis finds.

Read more from @guardian 👇👀

#Glyphosate #BanGlyphosate #HealthNotToxics

theguardian.com/business/2021/…

According to what was revealed by the newspapers Le Monde, The Guardian, Der Spiegel and De Standaard, however, the majority of the 53 studies that were submitted to the European Union to inform the decision would not meet sufficient quality criteria. This is a particularly significant piece of news, not only because it raises doubts about the reliability of the analyses, but also because, until now, the latter had remained entirely secret.

glifosato manifestazione germania
A demonstration against glyphosate in Germany © Sean Gallup/Getty Images

"Most of the studies submitted to the European Union are a disaster"

No one, before the two Austrian researchers — toxicologists specialising in oncology at the Institute for Cancer Research at the University of Vienna — had therefore been able to scrutinise the documents. And the verdict, indeed, is unequivocal: "Some of these studies are acceptable, but most are a disaster," they explained. Moreover, a proportion of these studies was carried out by the very companies that produce the pesticides: it is hard to imagine that they could be truly independent.

Further doubts are also raised by a French study, conducted by the National Institute of Health and Medical Research (Inserm). The conclusions reached by the researchers indicate that there are "strong suspicions" of a link between exposure to glyphosate and the onset of six serious diseases: three types of cancer (prostate cancer, non-Hodgkin lymphomas and multiple myelomas), Parkinson's disease, cognitive disorders and chronic obstructive pulmonary disease.

📢 L'INSERM établit une "présomption forte" de lien entre le #chlordecone et les cancers de la prostate ; des liens étant par ailleurs établis entre différents #pesticides dont le #glyphosate et les leucémies pour les enfants.

Nous demandons #justice.
google.com/amp/s/la1ere.f…

A definitive decision on a possible renewal of authorisations for glyphosate will have to be reached by the end of next year. The battle of studies and reports has therefore only just begun. The hope is that decision-makers will act on the basis of the precautionary principle.